Reshma Rangwala
Chief Tech/Sci/R&D Officer at KARYOPHARM THERAPEUTICS INC.
Net worth: 517 826 $ as of 2024-03-30
Reshma Rangwala active positions
| Companies | Position | Start | End |
|---|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Chief Tech/Sci/R&D Officer | 2022-03-31 | - |
Career history of Reshma Rangwala
Former positions of Reshma Rangwala
| Companies | Position | Start | End |
|---|---|---|---|
| ARAVIVE, INC. | Chief Tech/Sci/R&D Officer | 2020-09-14 | 2022-03-27 |
Genmab, Inc.
 Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Chief Tech/Sci/R&D Officer | 2017-04-30 | 2020-06-30 |
| MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 2012-05-31 | 2017-04-30 |
Training of Reshma Rangwala
| Duke University | Undergraduate Degree |
| The University of Cincinnati College of Medicine | Doctorate Degree |
Statistics
International
| United States | 7 |
Operational
| Chief Tech/Sci/R&D Officer | 4 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| ARAVIVE, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Genmab, Inc.
Genmab, Inc. Miscellaneous Commercial ServicesCommercial Services Genmab, Inc. creates and develops human antibodies for the treatment of life-threatening and debilitating diseases. It also offers products for cancer and autoimmune disorders. The company is headquartered in Princeton, NJ. | Commercial Services |
- Stock Market
- Insiders
- Reshma Rangwala
- Experience